Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics

BACKGROUND: Non-adherence to antipsychotic therapy among patients with schizophrenia is a key driver of relapse, which can lead to costly inpatient stays. Long-acting injectables (LAIs) may improve adherence, thus reducing hospitalizations, but inpatient cost reductions need to be balanced against h...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesa, Jacqueline A., Muser, Erik, Montejano, Leslie B., Smith, David M., Meyers, Oren I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674518/
https://www.ncbi.nlm.nih.gov/pubmed/26689953
http://dx.doi.org/10.1007/s40801-015-0043-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674518/
https://www.ncbi.nlm.nih.gov/pubmed/26689953
http://dx.doi.org/10.1007/s40801-015-0043-4

Ejemplares similares